<DOC>
	<DOCNO>NCT02498860</DOCNO>
	<brief_summary>Two-Year Disease Free Survival Rate Stage IB~IIIA adenocarcinoma Adjuvant Chemotherapy Pemetrexed Cisplatin assess . A total 106 patient recruit 12 month , follow two year , thus duration study 36 month .</brief_summary>
	<brief_title>Efficacy Safety Adjuvant Pemetrexed Plus Cisplatin Adenocarcinoma Lung</brief_title>
	<detailed_description>Primary endpoint : 2 year disease free survival Secondary endpoint : Overall survival , Frequency severity adverse event</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Adenocarcinoma Lung Postoperative pathologic stage IB~IIIA Complete surgical resection ( R0 resection ) N12 : R0 resection lobectomy mediastinal lymph node dissection ( MLND ) N0 : R0 resection lobectomy without MLND Adjuvant treatment start 4 6 week surgery ECOG performance status 01 Weight loss last 3 month less 10 % . Normal hematologic , hepatic renal function Neutrophil count &gt; 1500 /microliter , Platelet &gt; 100,000/microliter , Hemoglobin &gt; 9 g/dL Bilirubin &lt; =1.5 x upper limit normal , transaminase &lt; 2.5 x upper limit normal Serum Creatinine &lt; =1.5 mg/dL Women child bear age consent use contraceptive measure , must negative pregnancy test . Other malignant neoplastic disease within 5 year . Neoadjuvant chemotherapy surgery lung cancer Patients treat postoperative radiation . Stage IIIB IV lung cancer Severe infection , cardiorespiratory , hematologic illness HIV positive case Pregnancy lactate woman Autoimmune diseases receive immune suppressive treatment Symptomatic neuropathy &gt; CTCAE grade 1 Those consent clinical trial within 3 month Other significant medical condition contraindicate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>adenocarcinoma</keyword>
	<keyword>lung</keyword>
	<keyword>adjuvant chemotherapy</keyword>
	<keyword>pemetrexed</keyword>
	<keyword>cisplatin</keyword>
	<keyword>surgery</keyword>
</DOC>